ABOUT THE CONFERENCE
The scientific advancement of in-vitro diagnostics is extraordinary, providing physicians and patients with lifesaving information impacting the course of treatment and care across a plethora of disease states. From next generation sequencing through to point-of-care testing, the diagnostic industry faces continuous hurdles in demonstrating value to ultimately secure coverage and reimbursement from payers. Going on its 10th year, over one thousand industry stakeholders have taken part in the Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference to discuss and debate changes in the industry while at the same time, acquire tangible solutions to overcoming barriers to coverage.
The 10th Semi-Annual conference will delve into crucial issues for 2017 taking into account the evolving payer landscape as well as the integration of PAMA. Establishing clinical utility with commercial payers and CMS will be a foundational topic of the agenda. Further areas of investigation include risk sharing agreements as they can be applied to diagnostics, best practices in engaging payers in medical conversations, processes for winning claims and denials and insight on the growth of lab benefit management providers.
Can’t make these dates? We’re hosting this Diagnostic Coverage and Reimbursement Conference again on February 9-10, 2017 in San Diego, CA.